Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117171) titled 'A Comparison of Two Diabetes Medicines, Vildagliptin and Teneligliptin in Controlling Blood Sugar and Improving Cholesterol Levels in People with Type 2 Diabetes' on Sept. 7.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:An Open list of random numbers Blinding and masking:Open Label
Primary Sponsor: Government Stanley Medical College
Condition:
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Intervention:
Intervention1: TENELIGLIPTIN 20mg...